Future directions for recombinant interleukin-2 in cancer: a chronic inflammatory disorder.
Lotze
M T
MT
D016207:Cytokines / Q000502:physiology; D007249:Inflammation / Q000188:drug therapy / Q000503:physiopathology*; D007376:Interleukin-2 / Q000502:physiology* / Q000627:therapeutic use*; D009369:Neoplasms / Q000628:therapy*; D011994:Recombinant Proteins / Q000627:therapeutic use
D016207:Cytokines; D007376:Interleukin-2; D011994:Recombinant Proteins